Skip to main content

Table 6 Probability of dose de-escalation based on true risk of death in a given patient cohort

From: Assessment of precision irradiation in early non-small cell lung cancer and interstitial lung disease (ASPIRE-ILD): study protocol for a phase II trial

True Risk of Death in a Given Cohort

Probability of De-Escalation for that Cohort

0.08

10%

0.15

28%

0.30

67%

  1. aAt risk levels higher than 30%, which are thought to be extremely unlikely, dose de-escalation probabilities rise further, and chances of de-escalation within the first few patients are very high
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us